Claim 1: Prescription drugs in the U.S. cost 5 to 10 times more than in other countries.
Partially True.
• U.S. drug prices are significantly higher than in most developed nations.
• On average, Americans pay 2 to 4 times more, not always 5 to 10 times.
• Example: Insulin, Humira, and some cancer meds are many times more expensive in the U.S. compared to Canada, Germany, or the UK.
⸻
Claim 2: The same drug, made in the same lab, costs far more in the U.S. than elsewhere.
True.
• U.S. prices are not based on manufacturing costs but what the market will bear.
• The same exact drugs made by the same companies are cheaper overseas due to price controls and government negotiations.
⸻
Claim 3: Drug companies blame high prices on research and development (R&D).
True, but misleading.
• Pharma often cites R&D as justification.
• But R&D costs are often recouped within a few years, while prices remain high for much longer.
• The U.S. effectively subsidizes global R&D by allowing companies to charge more here than anywhere else.
⸻
Claim 4: Campaign contributions influence drug pricing policy.
True.
• The pharmaceutical industry is one of the top lobbyists in Washington.
• Both parties receive donations, but Trump is misleading when he says only Republicans are unbought.
• In 2020, Trump took millions from pharmaceutical PACs and super PACs.
⸻
Claim 5: Trump signed an Executive Order instituting a “Most Favored Nation” pricing policy.
True, but it never took effect.
• He did sign it in 2020.
• It aimed to peg U.S. drug prices to the lowest price in similar nations.
• Drug companies sued, and the courts blocked it.
• Biden later proposed a different strategy focused on Medicare price negotiations, which was passed in the Inflation Reduction Act.
⸻
Claim 6: The Executive Order would save “trillions of dollars.”
False.
• Nonpartisan estimates say tens to hundreds of billions at most over 10 years, not trillions.
• Trump massively overstates the financial impact.
⸻
Claim 7: The U.S. would be treated fairly and citizens would see prices slashed 30–80%.
False/Exaggerated.
• Even aggressive reforms are expected to reduce prices by 20–40%, mostly for Medicare users.
• A cut of 80% across the board is unrealistic unless the U.S. imposes strict price controls, which conservatives generally oppose.
Quote
The Kobeissi Letter
@KobeissiLetter
BREAKING: President Trump posts his "most important and impactful" Truth statement of all time.
In summary, President Trump will be signing an Executive Order tomorrow to reduce drug prices by 30% to 80%.
Who can reply?
Accounts @FL8ThomasMix follows or mentioned can reply